Skip to content

Human Subjects Protection Unit (HSPU)

The Human Subjects Protection Unit (HSPU) is made up of clinicians who function as Clinical Research Advocates (CRAs) to assess, develop and implement human subjects’ protections for potentially vulnerable participants enrolling in research. HSPU functions include: assessing and monitoring NIMH participants, consulting with researchers and the Combined NeuroScience Institutional Review Board (CNS IRB), and training researchers to obtain informed consent. The HSPU CRAs are also on the Ability to Consent Assessment Team (ACAT), which provides these services throughout the NIH Clinical Center upon request.

The HSPU provides the following human subjects protections per protocol requirement or researcher request:

Capacity Assessment

Protocol-specific assessment tools are developed and administered to determine a potential participant’s ability to provide informed consent. Capacity assessments may be mandated by the CNS IRB or requested by the researcher.

Ability to Assign a Surrogate Decision-Maker

When a protocol is approved for surrogate decision-maker consent, CRAs assess the potential participant’s ability to identify a surrogate decision-maker for healthcare decisions in research and may assist the potential participant with the process of completing the NIH Advance Directive for Health Care and Medical Research Participation form.

Surrogate Decision-Maker Assessment

For protocols approved to enroll a potential subject through surrogate consent, CRAs assess the surrogate decision-maker's understanding of the specific protocol and willingness to serve in this capacity.

Consent Monitoring

CRAs monitor and document the quality of the informed consent conversation between the researcher and potential participant. This ensures the potential participant understands the required elements of the consent and agrees to participate.

Assent Monitoring

This process protects the rights of minors and adults without decision-making capacity by ensuring the quality of the assent discussion and verifying the agreement of the potential participant to participate in research. This monitoring may be protocol mandated or requested by the researcher.

Subject Monitoring

For all NIMH inpatient protocols, CRAs verify ongoing informed consent through regular visits with subjects over the course of their participation to assess current wishes, understanding and concerns regarding continued participation in the protocol.

Consultation

CRAs consult with the CNS IRB and researchers regarding appropriate human participants’ protections for enrolling potentially vulnerable subjects. This may include assistance in the application of federal, NIH, Clinical Center and NIMH human subjects research regulations and policies. Additionally, CRAs are available to review protocols prior to initial submission to the CNS IRB for appropriate protections for potentially vulnerable populations.

Training, Education & Presentations

CRAs provide trainings throughout the Clinical Center on a wide-range of topics related to human subjects’ protections for potentially vulnerable populations. The Elements of a Successful Informed Consent is a required training for all researchers obtaining informed consent whose protocols are under the auspices of the CNS IRB. CRAs administer an Objective Structured Clinical Examination (OSCE) for the Informed Consent Process to researchers to evaluate their professionalism, communication skills as well as the quality of the informed consent process.

To view an online video about conducting a successful informed consent, go to www.youtube.com/watch?v=l26hdCD9g2I

OCD Staff / Clinical Research Advocates (CRAs)

Julie Brintnall-Karabelas, MSW, LCSW-C
301-402-6787

Carol J. Squires, MSSW, LCSW
301-402-6845

Katherine W. Todman, MSW, LCSW-C
301-496-8782

HSPU Phone 301-232-2984 
Pager 102-11158
FAX 301-402-6872
nimhhspu@mail.nih.gov